Emergent BioSolutions EVP Corporate Affairs Allen Shofe Appointed To MdBio Foundation Board Of Directors

Emergent BioSolutions Inc. (NYSE:EBS) announced today that Allen Shofe, executive vice president of corporate affairs, has been appointed to serve on the board of directors of the MdBio Foundation, a private charitable organization whose mission is to support bioscience awareness, education, and workforce development in Maryland. MdBio Foundation is an affiliate of the Tech Council of Maryland.

“I am honored to serve on the board of a Foundation that is committed to training and investing in tomorrow’s scientific talent, which is one of four focus areas of Emergent’s GIVE corporate social responsibility program,” said Mr. Shofe. “For years, Emergent has partnered with MdBio Foundation to host the Young Science Explorers program (YSEP) at our Gaithersburg laboratory facility providing middle school students a glimpse into biopharmaceutical product development and an opportunity to interact with employees and scientists about STEM-based careers. We look forward to again welcoming YSEP at our facility in July.”

Emergent’s GIVE CSR program (Give, Invest, and Volunteer in Emergent communities) is designed around a well-defined mission and focus areas – to build a healthier and safer world by advancing global health, protecting those who protect us, educating tomorrow’s scientific leaders, and improving the communities in which we live and work. The program enables the company, sites, and employees to contribute time, skills, and resources to support organizations through a wide range of philanthropic activities.

“Our GIVE program can have a rewarding and enduring effect on our communities, and motivate and invigorate employee achievement. Partnering with MdBio Foundation is one of the many ways we can work together to impact the local community,” said Mr. Shofe.

About Emergent BioSolutions

Emergent BioSolutions is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information may be found at www.emergentbiosolutions.com. Follow us on twitter: @emergentbiosolu.

If you liked this article you might like

Biotech movers: Ionis Drops After GSK Bows Out of Partnership

Emergent BioSolutions (EBS) Highlighted As Weak On High Volume

New Lifetime High For Emergent BioSolutions (EBS)

New Lifetime High Reached By Emergent BioSolutions (EBS)

New Lifetime High Reached: Emergent BioSolutions (EBS)